查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1699460

全球鏈球菌感染疾病治療市場按治療類型、給藥途徑、疾病類型、通路和地區分類

Global Strep Throat Treatment Market, By Treatment Type, By Route of Administration, By Disease Type, BY Distribution Channel, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 220 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計 2025 年全球感染疾病治療市場規模為 20.8 億美元，到 2032 年將達到 28.5 億美元，2025 年至 2032 年的複合年成長率為 4.6%。

報告範圍 報告詳細資訊
基準年 2024 2025年的市場規模 20.8億美元
效能數據 從2020年到2024年 預測期 2025年至2032年
預測期：2025-2032年複合年成長率： 4.60% 2032年價值預測 28.5億美元
數字。 2025年全球市場佔有率鏈球菌感染疾病治療市場各地區佔有率（%）
全球鏈球菌性咽喉炎治療市場-IMG1

鏈球菌是由 A 型鏈球菌 (GAS)感染疾病的細菌感染疾病，會導致喉嚨和扁桃體發炎和疼痛。感染疾病在 5 至 15 歲的兒童中特別常見。根據 2022 年成立的研究機構拉霍亞免疫學研究所最近的估計，鏈球菌性感染疾病每年影響全球超過 6 億人。如果不及時治療，它會導致各種其他嚴重的健康併發症，如風濕熱和腎臟疾病。目前的感染疾病感染治療市場依賴青黴素和阿莫西林等抗生素藥物。然而，抗生素抗藥性的增加帶來了重大挑戰。因此，製藥公司正致力於開發新藥和治療方法，以有效控制鏈球菌感染疾病。

市場動態：

全球鏈球菌感染疾病治療市場的成長是由全球鏈球菌感染疾病盛行率的增加所推動的。據估計，光是在美國，每年就有超過 1,800 萬例鏈球菌性咽喉炎感染疾病。此外，人們健康意識的增強和非處方藥的易得性也推動了市場的成長。然而，大多數鏈球菌感染疾病都是自限性的，這可能會限制市場潛力。此外，替代治療方法的開發需要較長的開發週期和較高的投資成本，這阻礙了創新研究活動。此外，非專利抗生素市場已經飽和，進一步限制了強勁產生收入的機會。儘管如此，市場上仍有機會透過新的藥物輸送技術和針對鏈球菌感染疾病的疫苗來滿足未滿足的需求。

大眾的健康意識日益增強，越來越多的人尋求及時的醫療建議和治療，以緩解症狀並預防風濕熱等併發症。透過改善醫療保健服務和資訊資源，可以進一步加強人們的這種認知，從而促進及時治療鏈球菌感染疾病。非處方藥（OTC）是症狀管理的首選，並推動了 OTC 市場的發展。這些藥物的隨時可用可以為患者提供與鏈球菌性感染疾病相關的咽喉痛症狀的即時緩解，從而促進整個市場的成長。然而，由於大多數鏈球菌感染疾病具有自限性，症狀無需治療即可消退，因此患者可能會選擇家庭治療方法或放棄藥物干預，從而阻礙市場成長潛力。開發鏈球菌咽頭炎的新治療方法是一項昂貴且耗時的工作，通常需要很長的開發週期。高昂的投資成本可能會阻礙力創新研究和藥物開發。然而，針對病原體 A 型鏈球菌的藥物輸送機制和疫苗的開發有市場機會。新的藥物配方和輸送技術可以提高治療效果和可用性，疫苗有可能顯著降低感染疾病的發生率。我們還能夠引入快速診斷工具，以便早期準確地發現咽部鏈球菌感染疾病，從而採取適當的治療性介入並減少不必要的抗生素使用。

例如，2021 年 9 月，製藥公司林肯製藥宣布收購位於梅赫薩納的一家工廠，該工廠生產用於治療肺炎和支氣管炎等疾病的抗生素。

本研究的主要特點

  • 本報告對全球鏈球菌感染疾病治療市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模和年複合成長率（CAGR%）。
  • 它還揭示了不同領域的潛在商機，並說明了該市場的有吸引力的投資提案矩陣。
  • 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
  • 它根據公司亮點、產品系列、關鍵亮點、績效和策略等參數，介紹了全球鏈球菌感染疾病治療市場的主要企業概況。
  • 本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
  • 全球鏈球菌感染疾病治療市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
  • 相關人員可以透過用於分析全球鏈球菌感染疾病治療市場的各種策略矩陣輕鬆做出決策。

目錄

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map（COM）

第3章市場動態、法規與趨勢分析

  • 市場動態
  • 影響分析
  • 主要亮點
  • 監管情景
  • 產品發布/核准
  • PEST分析
  • 波特分析
  • 併購場景

4. 全球鏈球菌感染疾病治療市場-冠狀病毒（COVID-19）大流行的影響

  • COVID-19流行病學
  • 供需側分析
  • 經濟影響

5. 2020 年至 2032 年全球鏈球菌感染疾病治療市場（依治療類型）

  • 抗生素
  • 阿莫西林
  • 青黴素
  • 其他
  • 止痛藥
  • 其他

6. 2020 年至 2032 年按給藥途徑分類的全球鏈球菌感染疾病治療市場

  • 口服
  • 局部的
  • 注射

7. 2020 年至 2032 年全球鏈球菌感染疾病治療市場（依疾病類型）

  • 急性鏈球菌咽頭炎
  • 咽頭炎
  • 扁桃腺炎
  • 喉炎
  • 其他

8. 2020 年至 2032 年全球鏈球菌感染疾病治療市場（依通路分類）

  • 醫院藥房
  • 零售藥局
  • 網路藥局

9. 2020 年至 2032 年全球鏈球菌感染疾病治療市場（按地區）

  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東
  • 非洲

第10章 競爭格局

  • Pfizer Inc.
  • Sanofi
  • Astrazeneca
  • Novartis AG
  • Bayer AG
  • GSK plc
  • Melinta Therapeutics
  • Amgen Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Limited
  • Merck & co, Inc.
  • Johnson & Johnson Service, Inc.
  • Accord Healthcare
  • Amneal Pharmaceuticals LLC.
  • MiddleBrook Pharmaceuticals, Inc.
  • Taiho Pharmaceutical Co., Ltd

第 11 章 章節

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI6635

Global Strep Throat Treatment Market is estimated to be valued at USD 2.08 Bn in 2025 and is expected to reach USD 2.85 Bn by 2032, growing at a compound annual growth rate (CAGR) of 4.6% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 2.08 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 4.60% 2032 Value Projection: USD 2.85 Bn
Figure. Global Strep Throat Treatment Market Share (%), By Region 2025
Global Strep Throat Treatment Market - IMG1

Strep throat is a bacterial infection caused by Group A Streptococcus (GAS) that results in an inflammation and soreness of the throat and tonsils. It is a very common infectious disease, especially among children aged 5-15 years. According to recent estimates provided by La Jolla Institute for Immunology, a research institute in 2022, strep throat affects over 600 million people globally each year. If left untreated, it can lead to various other severe health complications like rheumatic fever and kidney disease. The current market for strep throat treatment relies on antibiotic medications like penicillin and amoxicillin to clear the bacterial infection. However, increasing antibiotic resistance is posing a major challenge. As a result, pharmaceutical companies are focusing on developing new drugs and treatment options to effectively manage strep throat infections.

Market Dynamics:

Global strep throat treatment market growth is driven by rising prevalence of Strep throat infections worldwide. It is estimated that over 18 million cases of Strep throat occur in the U.S. alone each year. The market growth is also boosted by growing health awareness and easy availability of over-the-counter treatment drugs. However, the market potential can be restricted due to the self-limiting nature of most strep throat infections. Developing alternative treatment approaches also involves long development cycles and high investment costs which hinders innovative research activities. Moreover, market saturation of generic antibiotic drugs further limits robust revenue generation opportunities. Nevertheless, the market is presented with opportunities to address the unmet needs through novel drug delivery technologies and vaccines against Strep throat.

Health awareness among the general populace has increased, with more people seeking prompt medical advice and treatment for symptomatic relief and to prevent complications such as rheumatic fever. This awareness is bolstered by greater access to healthcare services and information resources that encourage timely treatment of Strep throat. Over-the-counter (OTC) medications serve as an initial resort for symptom management, driving the OTC segment of the market. The easy availability of these drugs contributes to the overall market growth, providing patients with immediate access to relief from sore throat symptoms associated with Strep infections. However, the inherent self-limiting nature of most Strep throat infections, where symptoms resolve without treatment, can impede market growth potential as individuals may opt for home remedies or choose not to pursue pharmaceutical interventions. Developing new and improved treatments for Strep throat can be a costly and time-intensive endeavor, often marked by long development cycles. High investment costs can act as a deterrent for innovative research and drug development. Yet, opportunities within the market lie in the advancement of drug delivery mechanisms and the development of vaccines against the causative bacteria, Group A Streptococcus. Novel drug formulations and delivery technologies can enhance treatment efficacy and user experience, while vaccines could significantly reduce the incidence of infections. The market is also ready for the introduction of rapid diagnostic tools, which could facilitate early and accurate detection of Strep throat infections, allowing for appropriate treatment interventions and reducing unnecessary use of antibiotics.

For instance, in September 2021, Lincoln Pharmaceuticals Ltd, a pharmaceutical company, announced the acquisition of facility in Mehsana that makes antibiotics used in the treatment of pneumonia and bronchitis, among other ailments.

Key features of the study:

  • This report provides in-depth analysis of the global strep throat treatment market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global strep throat treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Pfizer Inc., Sanofi, Astrazeneca, Novartis AG, Bayer AG, GSK plc, Melinta Therapeutics, Amgen Inc., Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Merck & co, Inc., Johnson & Johnson Service, Inc., Accord Healthcare, Amneal Pharmaceuticals LLC., MiddleBrook Pharmaceuticals, Inc., and Taiho Pharmaceutical Co., Ltd
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global strep throat treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global strep throat treatment market

Global Strep Throat Treatment Market- Segmentation

  • By Treatment Type
    • Antibiotics
    • Amoxicillin
    • Penicillin
    • Others
    • Pain Relievers
    • Others
  • By Route of Administration
    • Oral
    • Topical
    • Injectable
  • By Disease Type
    • Acute Strep Throat
    • Pharyngitis
    • Tonsillitis
    • Laryngitis
    • Others
  • By Distribution Channel
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles
    • Pfizer Inc.
    • Sanofi
    • Astrazeneca
    • Novartis AG
    • Bayer AG
    • GSK plc
    • Melinta Therapeutics
    • Amgen Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Takeda Pharmaceutical Company Limited
    • Merck & co, Inc.
    • Johnson & Johnson Service, Inc.
    • Accord Healthcare
    • Amneal Pharmaceuticals LLC.
    • MiddleBrook Pharmaceuticals, Inc.
    • Taiho Pharmaceutical Co., Ltd

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Strep Throat Treatment Market, By Treatment Type
    • Global Strep Throat Treatment Market, By Route of Administration
    • Global Strep Throat Treatment Market, By Disease Type
    • Global Strep Throat Treatment Market, By Distribution Channel
    • Global Strep Throat Treatment Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Driver
    • Rising prevalence of streptococcal infections
    • Increasing awareness about streptococcal infections
    • Growing investments in research and development (R&D)
    • Government support and initiatives
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Strep Throat Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Strep Throat Treatment Market, By Treatment Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Antibiotics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Amoxicillin
  • Penicillin
  • Others
  • Pain Relievers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Global Strep Throat Treatment Market, By Route of Administration, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Topical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Injectable
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

7. Global Strep Throat Treatment Market, By Disease Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Acute Strep Throat
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Pharyngitis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Tonsillitis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Laryngitis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

8. Global Strep Throat Treatment Market, By Distribution Channel, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Hospital Pharmacy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Retail Pharmacy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Online Pharmacy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

9. Global Strep Throat Treatment Market, By Region, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032 ,(US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)
      • South Africa
      • North Africa
      • Central Africa

10. Competitive Landscape

  • Pfizer Inc.
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sanofi
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Astrazeneca
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Novartis AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Bayer AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • GSK plc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Melinta Therapeutics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Amgen Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Teva Pharmaceutical Industries Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Takeda Pharmaceutical Company Limited
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Merck & co, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Johnson & Johnson Service, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Accord Healthcare
  • Amneal Pharmaceuticals LLC.
  • MiddleBrook Pharmaceuticals, Inc.
  • Taiho Pharmaceutical Co., Ltd
  • Analyst Views

11. Section

  • Research Methodology
  • About us